To help you develop a deeper understanding of the precision cancer medicine approach and the work being done at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) in this area, we have compiled the following list of patient resources.
More about DF/BWCC and Precision Cancer Medicine
- Paths of Progress Spring/Summer 2014 Unleashing the Potential
- Read Oncology Advances, a DF/BWCC newsletter detailing the latest work being done in oncology research and treatment.
- What patients should know about clinical trials
- Learn more about the Cancer Research Study being conducted by DF/BWCC. Download the adult consent brochure for some helpful FAQs.
- The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).
- National Human Genome Research Institute, Patients section
- The National Cancer Institute, the Federal Government’s principal agency for cancer research and training
- Dictionary of Genetics Terms
- Jay Bradner, Associate Professor, Department of Medicine, Harvard Medical School Associate and Director, Center for the Science of Therapeutics, Broad Institute, presents a TED talk on sharing cancer research: “Open Source Cancer Research.”
- Edward J. Benz, Jr, MD, President and Chief Operation Officer at Dana-Farber Cancer Institute talks about precision cancer medicine at the TEDx UMass Boston event: “Lighting the Way for the Future.”